Back to Search
Start Over
Dose optimization of valproic acid in a lethal model of traumatic brain injury, hemorrhage, and multiple trauma in swine.
- Source :
-
The journal of trauma and acute care surgery [J Trauma Acute Care Surg] 2019 Nov; Vol. 87 (5), pp. 1133-1139. - Publication Year :
- 2019
-
Abstract
- Background: Trauma is a leading cause of death, and traumatic brain injury is one of the hallmark injuries of current military conflicts. Valproic acid (VPA) administration in high doses (300-400 mg/kg) improves survival in lethal trauma models, but effectiveness of lower doses on survival is unknown. This information is essential for properly designing the upcoming clinical trials. We, therefore, performed the current study to determine the lowest dose at which VPA administration improves survival in a model of lethal injuries.<br />Methods: Swine were subjected to traumatic brain injury (10-mm cortical impact), 40% blood volume hemorrhage, and multiple trauma (femur fracture, rectus crush, and Grade V liver laceration). After 1 hour of shock, animals were randomized (n = 6/group) to four groups: normal saline (NS) resuscitation; or NS with VPA doses of 150 mg/kg (VPA 150) or 100 mg/kg (VPA 100) administered over 3 hours or 100 mg/kg over 2 hours (VPA 100 over 2 hours). Three hours after shock, packed red blood cells were given, and animals were monitored for another 4 hours. Survival was assessed using Kaplan-Meier and log-rank test.<br />Results: Without resuscitation, all of the injured animals died within 5 hours. Similar survival rates were observed in the NS (17%) and VPA 100 (0%) resuscitation groups. Survival rates in the 100-mg/kg VPA groups were significantly (p < 0.05) better when it was given over 2 hours (67%) compared to 3 hours (0%). 83% of the animals in the VPA 150 group survived, which was significantly higher than the NS and VPA 100 over 3 hours groups (p < 0.05).<br />Conclusion: A single dose of VPA (150 mg/kg) significantly improves survival in an otherwise lethal model of multiple injuries. This is a much lower dose than previously shown to have a survival benefit and matches the dose that is tolerated by healthy human subjects with minimal adverse effects.<br />Level of Evidence: Therapeutic, level V.
- Subjects :
- Animals
Brain Injuries, Traumatic complications
Brain Injuries, Traumatic mortality
Disease Models, Animal
Dose-Response Relationship, Drug
Erythrocyte Transfusion
Female
Humans
Multiple Trauma complications
Multiple Trauma mortality
Shock, Hemorrhagic etiology
Shock, Hemorrhagic mortality
Survival Rate
Sus scrofa
Brain Injuries, Traumatic therapy
Multiple Trauma therapy
Resuscitation methods
Shock, Hemorrhagic therapy
Valproic Acid administration & dosage
Subjects
Details
- Language :
- English
- ISSN :
- 2163-0763
- Volume :
- 87
- Issue :
- 5
- Database :
- MEDLINE
- Journal :
- The journal of trauma and acute care surgery
- Publication Type :
- Academic Journal
- Accession number :
- 31389922
- Full Text :
- https://doi.org/10.1097/TA.0000000000002460